PulmIQ is the world's first platform to treat snoring as what it clinically is — a lung disease signal, a cardiovascular signal, and a metabolic disease marker — combining respiratory science, behavioral psychology, and AI into one daily vital sign.
Two decades of peer-reviewed research confirm what no consumer app has ever acted on — snoring is simultaneously driving lung disease, cardiovascular disease, and metabolic disease. It is the single nightly signal that connects all three.
Your snoring is not just disrupting your sleep. Each night it is raising your blood pressure, driving insulin resistance, and accelerating lung decline — simultaneously.
A 0–100 composite index updating every 24 hours. No spirometer. No clinic. Just your phone, your wearable, and a validated algorithm designed to track toward clinical FEV₁ correlation.
Every data source maps directly to your Lung Score™ components.
PulmIQ gives every provider in the care pathway their own purpose-built clinical tool — connected by the same patient data.
The PulmIQ Physician Portal gives every prescribing physician a real-time dashboard of Lung Score™ trends, AHI trajectories, and exercise adherence — and automatically generates the RPM billing codes that pay for it.
The PulmIQ PT Portal is the first digital clinical tool purpose-built for physical therapists treating snoring — combining MSK assessment, IMT calibration, remote prescription delivery, and outcome tracking in one screen.
A new clinical category. No prior product, patent, or research protocol has combined acoustic respiratory phenotyping, physical therapy prescription delivery, behavioral psychology, PSG data integration, metabolic disease monitoring, AI coaching, and dual-portal billing automation in one platform. PulmIQ is the founding product.
Every app on the market tracks snoring. None of them treat it — and none connect it to the lung disease it's silently causing. PulmIQ closes that loop.
That is not a niche. That is cardiology, endocrinology, pulmonology, primary care, sleep medicine, allergy, and ENT — all managing the same unaddressed upstream problem.
Start free. Upgrade when you're ready to go clinical.
One signal, monitored nightly, that sits at the intersection of lung disease, cardiovascular disease, and metabolic disease. Join early access and be among the first to experience Psycho-Respiratory Sleep Medicine.